Viewing Study NCT02963935


Ignite Creation Date: 2025-12-24 @ 10:43 PM
Ignite Modification Date: 2026-01-03 @ 11:51 PM
Study NCT ID: NCT02963935
Status: COMPLETED
Last Update Posted: 2020-03-11
First Post: 2016-11-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-02-06
Start Date Type: ACTUAL
Primary Completion Date: 2018-05-23
Primary Completion Date Type: ACTUAL
Completion Date: 2018-06-19
Completion Date Type: ACTUAL
First Submit Date: 2016-11-10
First Submit QC Date: None
Study First Post Date: 2016-11-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-05-21
Results First Submit QC Date: None
Results First Post Date: 2019-07-30
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-02-28
Last Update Post Date: 2020-03-11
Last Update Post Date Type: ACTUAL